Leal Therapeutics
Highly Engaged Employees
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
17 Briden St Ofc 329, Worcester, Massach...Website
www.lealtx.comRevenue
<$5 MillionIndustry
About Leal Therapeutics
Leal Therapeutics Org Chart
Is Leal Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Leal Therapeutics recently announced quarterly report
Check if Leal Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Leal Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Leal Therapeutics
Product Launch: Get notified when Leal Therapeutics launches new products
Check out if Leal Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Leal Therapeutics has new funding data
Leal Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Leal Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Leal Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Leal Therapeutics.
Leal Therapeutics financials insights
Gather financial insights about Leal Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$45M
Series A
$30M
Leal Therapeutics Tech Stack
A closer look at the technologies used by Leal Therapeutics
Most Recent Scoops
Leal Therapeutics News & Media
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Leal Therapeutics is developing first-in-class therapeutics to correct metabolic imbalances in the brain for treatment of high unmet need CNS disorders Financing advances LTX-001 through clinical efficacy data in schizophrenia patients, LTX-002 through initial clinical data in ALS, and...Leal Therapeutics Raises $45M Financing
Leal Therapeutics, a Worcester, MA-based biotechnology company developing novel therapeutics for patients with disorders of the central nervous system (CNS), raised $45M in funding. The round was led by Newpath Partners, with additional new investors Chugai Venture Fund and Alexandria Venture Investments, in addition to existing investors OrbiMed, Euclidean Capital and PhiFund. In connection with […] The post Leal Therapeutics Raises $45M Financing appeared first on FinSMEs.
Top Business Services Companies
Frequently Asked Questions Regarding Leal Therapeutics
Leal Therapeutics is a biotechnology company dedicated to developing novel precision medicines for patients with high-need central nervous system disorders. Leal was launched in 2021 and is headquartered in Worcester, Mass.... Read More


